Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

The move would trigger an overhaul of scores of products on U.S. grocery store shelves. The plan was announced Tuesday ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...

Health care giant Johnson ... drug Risperdal to the company’s role in the nation’s opioid crisis. But Harris doesn’t spare others from scrutiny or criticism with his book. Namely, he focuses on what ...

(Reuters) -Johnson & Johnson Chief ... companies should work with the Trump administration to mitigate supply chain vulnerabilities and prevent any drug shortages that can result from tariffs.

Details were expected to be announced Tuesday afternoon by Health Secretary Robert F. Kennedy Jr. and Food and Drug ...

Harris is the author of “No More Tears: The Dark Secrets of Johnson & Johnson ... there were others with similar results, the Food and Drug Administration in May 2004 called a public hearing ...